Serological tests are blood tests conducted to detect and measure the concentration of antibodies against particular bacteria, virus, and any other foreign particle. Serological tests are widely used for the diagnosis of different types of bacterial, fungal, as well as viral infections. These tests have wide applications in diagnostic laboratories for the detection of infectious diseases, blood group typing, and diagnosis of autoimmune disorders. Different types of serological tests and techniques such as immunoassay tests, agglutination tests, and precipitation tests are available for the diagnosis of various disease conditions.
The global serological testing market is projected to be driven by high prevalence and rise in incidence rates of acute as well as infectious diseases such as hepatitis, tuberculosis, and HIV/AIDS across the world. According to statistical data published by hiv.gov, around 36.7 million people were living with HIV/AIDS across the globe in 2016. Moreover, the prevalence of hepatitis C infection was estimated to be around 71 million globally in 2017. New product development and approvals for serological tests for a variety of bacterial and viral infections are likely to drive the global serological testing market during the forecast period. However, high cost of serological tests and stringent government regulations are expected to hamper the growth of the global market during the forecast period.
Request a PDF Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=48468
The global serological testing market can be segmented based on type of serological test, application, end-user, and region. In terms of type of serological test, the global serological testing market can be classified into primary serological tests, secondary serological tests, and tertiary binding tests. The primary serological tests segment can be categorized based on marker techniques into enzyme linked immunosorbent assay (ELISA), immunoflurescent antibody technique (IFAT), and radio immunoassay (RIA). The secondary serological tests segment can be divided into agglutination tests, complement fixation tests (CFT), precipitation tests, serum neutralization tests (SNT), and toxin-antitoxin tests. The primary serological tests segment is projected to dominate the global serological testing market during the forecast period. In terms of application, the global serological testing market can be segmented into rotavirus infections, hepatitis, HIV, endotoxins, therapeutic drug monitoring, and other infectious diseases. The hepatitis segment is anticipated to expand at the highest CAGR during the forecast period. Based on end-user, the global serological testing market can be classified into hospitals, diagnostic laboratories, blood banks, academic & research institutes, and others.
Geographically, the global serological testing market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe is projected to account for the largest share of the global serological testing market owing to high prevalence of infectious diseases, well-established health care infrastructure, rise in number of geriatric population, and increase in awareness about various infectious and acute diseases in the region. North America is anticipated to account for the second largest share of the global serological testing market by 2026. Increase in the geriatric population, high prevalence and rise in incidence rates of HIV/AIDS, hepatitis, and other retroviral infections in the region contribute to the high share of the region. The serological testing market in Asia Pacific is expected to expand at the highest CAGR during the forecast period owing to large population with infectious diseases in countries such as India and China, increase in awareness, and surge in per capita health care expenditure in the region.
Request for Analysis of COVID19 Impact on Serological Testing Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=48468
The global serological testing market is highly fragmented, with large number of manufacturers holding prominent share in respective regions. Key players operating in the global serological testing market include Serological Research Institute (SERI), Chembio Diagnostic Systems, Inc., Advanced Diagnostics, Inc., Randox Laboratories Ltd., Eurofins Scientific, Becton, Dickinson and Company, Quest Diagnostics, ELITechGroup, Immucor, Thermo Fisher Scientific, Inc., Beckman Coulter, Inc. (subsidiary of Danaher Corporation), Creative Diagnostics, and Grifols.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Buy now Serological Testing Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=48468<ype=S
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
More Trending Reports by Transparency Market Research:
https://www.prnewswire.co.uk/news-releases/carbon-therapy-segment-in-particle-therapy-market-to-grow-at-exponential-growth-rate-from-2018-to-2026-tmr-848789727.html
https://www.prnewswire.com/news-releases/strides-in-positive-airway-pressure-devices-market-help-reduce-worldwide-prevalence-of-obstructive-sleep-apnea-valuation-to-rise-at-cagr-of-7-8-from-2019-to-2027-tmr-301136571.html
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/
